Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. What else is she supposed to do except ...

Boston, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bottom Line and Get Schooled, two leading college access nonprofits, announced today they have merged, establishing one of the most impactful national ...

KNR Constructions (₹134.50): The stock has been in a strong downtrend since August 2024. It has also broken the crucial long-term support level of ₹162. There is room for a further fall to ₹120-119, ...

https://www.thehindubusinessline.com/info-tech/microsoft-365-down-for-thousands-of-users-downdetector-shows/article70541183.ece Copy Microsoft’s suite of ...

What if I told you that a simple change could make your Power Query refresh from SharePoint up to 700% faster? If you’ve ever found yourself staring at a progress bar that refuses to budge, you’re not ...

Kevin Stefanski took the Atlanta Falcons head coaching job on Saturday night and he's already started putting together his staff. According to NFL Network insider Mike Garafolo, the Falcons are ...

United and City, as so often in recent years, are experiencing vastly contrasting seasons. And yet both come into this latest Manchester derby on the back of three straight Premier League draws. But ...

Meta Platforms Inc. has agreed to acquire Singapore-based AI startup Manus, which makes an artificial intelligence agent that it sells to small and medium-sized businesses. The deal is part of a ...

Rail company Amtrak recently rebranded a popular California line, combining rail and thruway bus service under one name: the Gold Runner. The line, formerly called the San Joaquins line, operates ...

Adding tucatinib to standard first-line maintenance therapy in patients with HER2-positive metastatic breast cancer led to a clinically meaningful delay in disease progression, regardless of the ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular lymphoma. The EPCORE FL-1 trial results show a 79% progression-free ...